Abstract
Background
Recently, aging has been shown to be associated with sarcopenic obesity (SO), of which decreased muscle mass and increased fat mass are features. Sarcopenia and obesity alone are known to be associated with abnormal lipid metabolism. However, it remains unclear whether SO has greater adverse effects on dyslipidemia than on sarcopenia or obesity alone.
Aim
We aimed to investigate the association between SO and dyslipidemia in elderly Koreans.
Subjects and methods
This study was based on data collected during the 2008–2010 Korea National Health and Nutrition Examination Survey. We included 1,466 men and 2,017 women aged 65 years and over. Sarcopenia was indicated in participants with height- or weight-adjusted appendicular skeletal muscle that was 1 standard deviation below the sex-specific mean for the young reference group, and obesity was defined as a body mass index ≥25 kg/m2. Dyslipidemia was defined according to the National Cholesterol Education Program-Adult Treatment Panel III.
Results
After adjusting for confounding factors, the SO group had a higher risk for dyslipidemia [odds ratio (OR) 2.82 (95 % confidence interval 1.76–4.51)] than the obese group [2.12 (1.11–4.07)] and sarcopenic group [1.46 (1.01–2.11)] (p < 0.001) only in men. Furthermore, the SO group in men had the highest OR for hypercholesterolemia, hypertriglyceridemia, hypo-high-density lipoprotein cholesterolemia, hyper-low-density lipoprotein cholesterolemia, and a high ratio of triglyceride to high-density lipoprotein cholesterol even after further adjustments.
Conclusions
In Korean elderly men, SO was associated with an increased risk for dyslipidemia compared with sarcopenia or obesity alone.
Similar content being viewed by others
Abbreviations
- ASM:
-
Appendicular skeletal muscle
- BMI:
-
Body mass index
- DBP:
-
Diastolic blood pressure
- FBG:
-
Fasting blood glucose
- HDL-C:
-
High-density lipoprotein cholesterol
- HOMA-IR:
-
Homeostasis model assessment of insulin resistance
- Ht:
-
Height
- KNHANES:
-
Korea National Health and Nutrition Examination Survey
- LDL-C:
-
Low-density lipoprotein cholesterol
- SBP:
-
Systolic blood pressure
- SO:
-
Sarcopenic obesity
- TC:
-
Total cholesterol
- TG:
-
Triglyceride
- WC:
-
Waist circumference
- Wt:
-
Weight
References
Lim S, Park KS, Lee HK, Cho SI (2005) Changes in the characteristics of metabolic syndrome in Korea over the period 1998–2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 28:1810–1812
Yamada M, Wong FL, Kodama K et al (1997) Longitudinal trends in total serum cholesterol levels in a Japanese cohort, 1958–1986. J Clin Epidemiol 50:425–434
Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V (2008) Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 18:388–395
Baumgartner RN (2000) Body composition in healthy aging. Ann N Y Acad Sci 904:437–448
Kim TN, Yang SJ, Yoo HJ et al (2009) Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond) 33:885–892
Lim S, Kim JH, Yoon JW et al (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 33:1652–1654
Roubenoff R (2000) Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci 904:553–557
Lu CW, Yang KC, Chang HH et al (2013) Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract 7:e301–e307
Kim JH, Hwang Bo Y, Hong ES et al (2010) Investigation of sarcopenia and its association with cardio metabolic risk factors in elderly subjects. J Korean Geriatr Soc 14:121–130
Stephen WC, Janssen I (2009) Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 13:460–466
Park H, Kim K (2012) Association of alcohol consumption with lipid profile in hypertensive men. Alcohol 47:282–287
Hanak V, Munoz J, Teague J, Stanley A Jr, Bittner V (2004) Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am J Cardiol 94:219–222
Natarajan S, Glick H, Criqui M et al (2003) Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50–57
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087–1092
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497
Lee SY, Park HS, Kim DJ et al (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75:72–80
Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763
Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50:889–896
Weisell RC (2002) Body mass index as an indicator of obesity. Asia Pac J Clin Nutr 11(Suppl 8):S681–S684
Lee MH, Kim HC, Ahn SV et al (2012) Prevalence of dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998–2005. Diabetes Metab J 36:43–55
Tóth PP, Potter D, Ming EE (2012) Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003–2006. J Clin Lipidol 6:325–330
Schrager MA, Metter EJ, Simonsick E et al (2007) Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 102:919–925
Goodpaster BH, Brown NF (2005) Skeletal muscle lipid and its association with insulin resistance: what is the role for exercise? Exerc Sport Sci Rev 33:150–154
Reaven GM (1997) Banting lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition 13:65 discussion 4, 6
Petersen KF, Dufour S, Savage DB et al (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci USA 104:12587–12594
Newman AB, Kupelian V, Visser M et al (2003) Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 51:1602–1609
Kim YS, Lee Y, Chung YS et al (2012) Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci 67:1107–1113
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423
Conflict of interest
The authors S. J. Baek, G. E. Nam, K. D. Han, S. W. Choi, S. W. Jung, A. R. Bok, Y. H. Kim, K. S. Lee, B. D. Han, and D. H. Kim declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
S. J. Baek and G. E. Nam authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Baek, S.J., Nam, G.E., Han, K.D. et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea National Health and Nutrition Examination Survey. J Endocrinol Invest 37, 247–260 (2014). https://doi.org/10.1007/s40618-013-0011-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-013-0011-3